131 related articles for article (PubMed ID: 33540355)
1. Systematic comparison of competitive and allosteric kinase inhibitors reveals common structural characteristics.
Hu H; Laufkötter O; Miljković F; Bajorath J
Eur J Med Chem; 2021 Mar; 214():113206. PubMed ID: 33540355
[TBL] [Abstract][Full Text] [Related]
2. Data set of competitive and allosteric protein kinase inhibitors confirmed by X-ray crystallography.
Hu H; Laufkötter O; Miljković F; Bajorath J
Data Brief; 2021 Apr; 35():106816. PubMed ID: 33604432
[TBL] [Abstract][Full Text] [Related]
3. Allosteric modulation of kinases and GPCRs: design principles and structural diversity.
Lewis JA; Lebois EP; Lindsley CW
Curr Opin Chem Biol; 2008 Jun; 12(3):269-80. PubMed ID: 18342020
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site.
Chen H; Tucker J; Wang X; Gavine PR; Phillips C; Augustin MA; Schreiner P; Steinbacher S; Preston M; Ogg D
Acta Crystallogr D Struct Biol; 2016 May; 72(Pt 5):682-93. PubMed ID: 27139631
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of three-dimensional activity cliffs formed by kinase inhibitors with different binding modes and cliff mapping of structural analogues.
Furtmann N; Hu Y; Bajorath J
J Med Chem; 2015 Jan; 58(1):252-64. PubMed ID: 25054653
[TBL] [Abstract][Full Text] [Related]
6. Exploring the scaffold universe of kinase inhibitors.
Hu Y; Bajorath J
J Med Chem; 2015 Jan; 58(1):315-32. PubMed ID: 25192260
[TBL] [Abstract][Full Text] [Related]
7. Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights.
Cherry M; Williams DH
Curr Med Chem; 2004 Mar; 11(6):663-73. PubMed ID: 15032722
[TBL] [Abstract][Full Text] [Related]
8. Detection of allosteric kinase inhibitors by displacement of active site probes.
Lebakken CS; Reichling LJ; Ellefson JM; Riddle SM
J Biomol Screen; 2012 Jul; 17(6):813-21. PubMed ID: 22453235
[TBL] [Abstract][Full Text] [Related]
9. Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.
Vieth M; Higgs RE; Robertson DH; Shapiro M; Gragg EA; Hemmerle H
Biochim Biophys Acta; 2004 Mar; 1697(1-2):243-57. PubMed ID: 15023365
[TBL] [Abstract][Full Text] [Related]
10. Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode.
Boffey HK; Rooney TPC; Willems HMG; Edwards S; Green C; Howard T; Ogg D; Romero T; Scott DE; Winpenny D; Duce J; Skidmore J; Clarke JH; Andrews SP
J Med Chem; 2022 Feb; 65(4):3359-3370. PubMed ID: 35148092
[TBL] [Abstract][Full Text] [Related]
11. The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors.
Lindsley CW; Barnett SF; Layton ME; Bilodeau MT
Curr Cancer Drug Targets; 2008 Feb; 8(1):7-18. PubMed ID: 18288939
[TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Analysis of the Allosteric Inhibition of IRE1α with ATP-Competitive Ligands.
Feldman HC; Tong M; Wang L; Meza-Acevedo R; Gobillot TA; Lebedev I; Gliedt MJ; Hari SB; Mitra AK; Backes BJ; Papa FR; Seeliger MA; Maly DJ
ACS Chem Biol; 2016 Aug; 11(8):2195-205. PubMed ID: 27227314
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.
Zhu X; Kim JL; Newcomb JR; Rose PE; Stover DR; Toledo LM; Zhao H; Morgenstern KA
Structure; 1999 Jun; 7(6):651-61. PubMed ID: 10404594
[TBL] [Abstract][Full Text] [Related]
14. Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α.
Brear P; Ball D; Stott K; D'Arcy S; Hyvönen M
J Med Chem; 2020 Nov; 63(21):12786-12798. PubMed ID: 33119282
[TBL] [Abstract][Full Text] [Related]
15. ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism.
Luo L; Parrish CA; Nevins N; McNulty DE; Chaudhari AM; Carson JD; Sudakin V; Shaw AN; Lehr R; Zhao H; Sweitzer S; Lad L; Wood KW; Sakowicz R; Annan RS; Huang PS; Jackson JR; Dhanak D; Copeland RA; Auger KR
Nat Chem Biol; 2007 Nov; 3(11):722-6. PubMed ID: 17922005
[TBL] [Abstract][Full Text] [Related]
16. An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein-inhibitor complexes.
Vulpetti A; Pevarello P
Curr Med Chem Anticancer Agents; 2005 Sep; 5(5):561-73. PubMed ID: 16178778
[TBL] [Abstract][Full Text] [Related]
17. Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related Compounds.
Laufkötter O; Hu H; Miljković F; Bajorath J
J Med Chem; 2022 Jan; 65(2):922-934. PubMed ID: 33476146
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors.
McInnes C; Wang S; Anderson S; O'Boyle J; Jackson W; Kontopidis G; Meades C; Mezna M; Thomas M; Wood G; Lane DP; Fischer PM
Chem Biol; 2004 Apr; 11(4):525-34. PubMed ID: 15123247
[TBL] [Abstract][Full Text] [Related]
19. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors.
Fischmann TO; Smith CK; Mayhood TW; Myers JE; Reichert P; Mannarino A; Carr D; Zhu H; Wong J; Yang RS; Le HV; Madison VS
Biochemistry; 2009 Mar; 48(12):2661-74. PubMed ID: 19161339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
